ReviewCells2022

Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge.

Omar Soler-Cedeno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.